Advanced search
Publication Cover
Expert Review of Molecular Diagnostics Volume 13, 2013 - Issue 4
Submit an article Journal homepage
217
Views
10
CrossRef citations to date
0
Altmetric
Editorial

Single molecular weight discrete PEG compounds: emerging roles in molecular diagnostics, imaging and therapeutics

Stephen P Povoski Arthur G James Cancer Hospital and Richard J Solove Research Institute and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA. [email protected]
,
Paul D Davis Quanta BioDesign, Ltd, Powell, OH 43065, USA
,
David Colcher Beckman Research Institute, City of Hope, Duarte, CA 91010, USA
&
Edward W Martin Jr Arthur G James Cancer Hospital and Richard J Solove Research Institute and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA
Pages 315-319 | Published online: 09 Jan 2014

References

  • Abuchowski A, van Es T, Palczuk NC, Davis FF. Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J. Biol. Chem. 252(11), 3578–3581 (1977).
  • Abuchowski A, McCoy JR, Palczuk NC, van Es T, Davis FF. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J. Biol. Chem. 252(11), 3582–3586 (1977).
  • Hershfield MS, Buckley RH, Greenberg ML et al. Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase. N. Engl. J. Med. 316(10), 589–596 (1987).
  • Levy Y, Hershfield MS, Fernandez-Mejia C et al. Adenosine deaminase deficiency with late onset of recurrent infections: response to treatment with polyethylene glycol-modified adenosine deaminase. J. Pediatr. 113(2), 312–317 (1988).
  • Roberts MJ, Bentley MD, Harris JM. Chemistry for peptide and protein PEGylation. Adv. Drug Deliv. Rev. 54(4), 459–476 (2002).
  • Veronese FM, Pasut G. PEGylation, successful approach to drug delivery. Drug Discov. Today 10(21), 1451–1458 (2005).
  • Jain A, Jain SK. PEGylation: an approach for drug delivery. A review. Crit. Rev. Ther. Drug Carrier Syst. 25(5), 403–447 (2008).
  • Ryan SM, Mantovani G, Wang X, Haddleton DM, Brayden DJ. Advances in PEGylation of important biotech molecules: delivery aspects. Expert Opin. Drug Deliv. 5(4), 371–383 (2008).
  • Jevsevar S, Kunstelj M, Porekar VG. PEGylation of therapeutic proteins. Biotechnol. J. 5(1), 113–128 (2010).
  • Pasut G, Veronese FM. State of the art in PEGylation: the great versatility achieved after forty years of research. J. Control. Release 161(2), 461–472 (2012).
  • Fee CJ, Van Alstine JM. PEG-proteins: reaction engineering and separation issues. Chem. Eng. Sci. 61, 924–939 (2006).
  • Gaberc-Porekar V, Zore I, Podobnik B, Menart V. Obstacles and pitfalls in the PEGylation of therapeutic proteins. Curr. Opin. Drug Discov. Devel. 11(2), 242–250 (2008).
  • Vreeland WN, Desruisseaux C, Karger AE, Drouin G, Slater GW, Barron AE. Molar mass profiling of synthetic polymers by free-solution capillary electrophoresis of DNA-polymer conjugates. Anal. Chem. 73(8), 1795–1803 (2001).
  • Hayashi G, Hagihara M, Nakatani K. Genotyping by allele-specific L-DNA-tagged PCR. J. Biotechnol. 135(2), 157–160 (2008).
  • Mizuta Y, Onodera T, Singh P, Matsumoto K, Miura N, Toko K. Development of an oligo(ethylene glycol)-based SPR immunosensor for TNT detection. Biosens. Bioelectron. 24(2), 191–197 (2008).
  • Nagatomo K, Kawaguchi T, Miura N, Toko K, Matsumoto K. Development of a sensitive surface plasmon resonance immunosensor for detection of 2,4-dinitrotoluene with a novel oligo (ethylene glycol)-based sensor surface. Talanta 79(4), 1142–1148 (2009).
  • Hsiao SC, Shum BJ, Onoe H et al. Direct cell surface modification with DNA for the capture of primary cells and the investigation of myotube formation on defined patterns. Langmuir 25(12), 6985–6991 (2009).
  • Lefever M, Kosmeder JW 2nd, Farrell M, Bieniarz C. Microwave-mediated synthesis of labeled nucleotides with utility in the synthesis of DNA probes. Bioconjug. Chem. 21(10), 1773–1778 (2010).
  • Kumar S, Tao C, Chien M et al. PEG-labeled nucleotides and nanopore detection for single molecule DNA sequencing by synthesis. Sci. Rep. 2, 684 (2012).
  • Wang L, Shi J, Kim YS et al. Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers. Mol. Pharm. 6(1), 231–245 (2009).
  • Fang W, He J, Kim YS, Zhou Y, Liu S. Evaluation of 99mTc-labeled cyclic RGD peptide with a PEG4 linker for thrombosis imaging: comparison with DMP444. Bioconjug. Chem. 22(8), 1715–1722 (2011).
  • Li L, Turatti F, Crow D et al. Monodispersed DOTA-PEG-conjugated anti-TAG-72 diabody has low kidney uptake and high tumor-to-blood ratios resulting in improved 64Cu PET. J. Nucl. Med. 51(7), 1139–1146 (2010).
  • Li L, Crow D, Turatti F et al. Site-specific conjugation of monodispersed DOTA-PEGn to a thiolated diabody reveals the effect of increasing peg size on kidney clearance and tumor uptake with improved 64-copper PET imaging. Bioconjug. Chem. 22(4), 709–716 (2011).
  • Smolensky ED, Park HY, Berquó TS, Pierre VC. Surface functionalization of magnetic iron oxide nanoparticles for MRI applications – effect of anchoring group and ligand exchange protocol. Contrast Media Mol. Imaging 6(4), 189–199 (2011).
  • Liu T, Nedrow-Byers JR, Hopkins MR, Berkman CE. Spacer length effects on in vitro imaging and surface accessibility of fluorescent inhibitors of prostate specific membrane antigen. Bioorg. Med. Chem. Lett. 21(23), 7013–7016 (2011).
  • Zhu L, Xie J, Swierczewska M et al. Real-time video imaging of protease expression in vivo. Theranostics 1, 18–27 (2011).
  • Kovtun YV, Audette CA, Mayo MF et al. Antibody-maytansinoid conjugates designed to bypass multidrug resistance. Cancer Res. 70(6), 2528–2537 (2010).
  • Novikov BN, Grimsley JK, Kern RJ, Wild JR, Wales ME. Improved pharmacokinetics and immunogenicity profile of organophosphorus hydrolase by chemical modification with polyethylene glycol. J. Control. Release 146(3), 318–325 (2010).
  • Arosio D, Manzoni L, Araldi EM, Scolastico C. Cyclic RGD functionalized gold nanoparticles for tumor targeting. Bioconjug. Chem. 22(4), 664–672 (2011).
  • Capon DJ, Kaneko N, Yoshimori T et al. Flexible antibodies with nonprotein hinges. Proc. Jpn. Acad., Ser. B, Phys. Biol. Sci. 87(9), 603–616 (2011).
  • Brinãs RP, Sundgren A, Sahoo P et al. Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines. Bioconjug. Chem. 23(8), 1513–1523 (2012).
  • Francis JN, Redman JS, Eckert DM, Kay MS. Design of a modular tetrameric scaffold for the synthesis of membrane-localized D-peptide inhibitors of HIV-1 entry. Bioconjug. Chem. doi:10.1021/bc300076f (2012) (Epub ahead of print).
  • Zhang L, Klein BD, Metcalf CS et al. Incorporation of monodisperse oligoethyleneglycol amino acids into anticonvulsant analogues of galanin and neuropeptide Y provides peripherally acting analgesics. Mol. Pharm. 10(2), 574–585 (2013).

Patents

  • Davis PD, Crapps EC. Selective and specific preparation of discrete PEG compounds. US7888536 (2011).
  • Kosmeder JW, Lefever M, Johnson D, Farrell M, Zhilina Z, Bieniarz C. Haptens, haptenconjugates, compositions thereof and method for their preparation and use. US7695929 (2010).
  • Garibay PW, Hoeg-Jensen T, Jonassen I, Havelund S, Madsen P, Jakobsen P. Insulin derivatives. US0171695 (2008).
  • Christensen L, Lau J, Spetzler J, Hansen TK. Dimeric peptide agonists of the GLP1 receptor. US0062192 (2009).
  • Heavner G. Melanocortin receptor binding conjugates. US0278845 (2010).
  • Aaronson JG, Barnett SF, Bartz R et al. Novel single chemical entities and methods for delivery of oligonucleotides. US0041133 (2013).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.